The article, “ENLIGHT: European network for Light ion hadron therapy” published in the most recent Radiotherapy and Oncology issue, chronicles 15 years of ENLIGHT, reflecting the power and need for collaboration. ENLIGHT has been extremely influential in its work related to hadron therapy (HT), including topics such as patient selection, clinical trials, technology, radiobiology, imaging and health economics. ENLIGHT was initiated through CERN and ESTRO and dealt with various disciplines such as (medical) physics and engineering, radiation biology and radiation oncology.
Radiotherapy and Oncology article, “ENLIGHT: European network for Light ion hadron therapy”